about
Administration of pure follicle-stimulating hormone during gonadotropin-releasing hormone agonist therapy in patients with clomiphene-resistant polycystic ovarian disease: hormonal evaluations and clinical perspectives.A prospective, randomised, controlled clinical study on the assessment of tolerability and of clinical efficacy of Merional (hMG-IBSA) administered subcutaneously versus Merional administered intramuscularly in women undergoing multifollicular ovariFertility counseling of young breast cancer patients.Storage time does not modify the gene expression profile of cryopreserved human metaphase II oocytes.Laparoscopic surgery in pregnancy. A case report with a brief review of the topic.Menstrual patterns, fertility and main pregnancy outcomes after allogeneic haematopoietic stem cell transplantation.Cancer and fertility preservation: international recommendations from an expert meeting.Multicenter observational study on slow-cooling oocyte cryopreservation: clinical outcome."Triple marker" for ectopic pregnancy.Hysterosalpingography with gadolinium.Peritoneal fluid proteome in women with different ASRM stages of endometriosis.Vitamin D binding protein in endometriosis.Strategies to minimize discomfort during diagnostic hysterosalpingography with disposable balloon catheters: a randomized placebo-controlled study with oral nonsteroidal premedication.Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?Mitochondrial DNA in Day 3 embryo culture medium is a novel, non-invasive biomarker of blastocyst potential and implantation outcome.Changes in sexual function after medical or surgical termination of pregnancy.Asthma in women with endometriosis.Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young breast cancer survivors?Results and unsolved problems following the amendment to the Italian Law on assisted reproduction brought about by the Constitutional CourtLuteinizing hormone-releasing hormone analog therapy of uterine fibroid: analysis of results obtained with buserelin administered intranasally and goserelin administered subcutaneously as a monthly depotGamete intrafallopian transfer and plasma chorionic gonadotropin dynamics: evidence of a delayed appearanceThe duration of pituitary suppression by means of intranasal gonadotropin hormone-releasing hormone analogue administration does not influence the ovarian response to gonadotropin stimulation and success rate in a gamete intrafallopian transfer (GIFEffects of gonadotrophin-releasing hormone agonist on uterine fibroids and bone densityMethodological concerns regarding levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosisFour year experience in laparoscopic dissection of intact ovarian dermoid cystsProteomic analysis of peritoneal fluid in women with endometriosisIncreased frequency of migraine among women with endometriosisIs VEGF a marker for ovarian response and pregnancy outcome?The involvement of the interstitial Cajal cells and the enteric nervous system in bowel endometriosisQuality of sex life in women with endometriosis and deep dyspareuniaHow complete is full thickness disc resection of bowel endometriotic lesions? A prospective surgical and histological studyFertility after bowel resection for endometriosisBody mass index in endometriosisTotal and active ghrelin levels in women with polycystic ovary syndromeWhat is the desired menstrual frequency of women without menstruation-related symptoms?Constitutional change of Italian legislation on assisted reproduction technology improves pregnancy rate especially in older patientsGonadotropin Releasing Hormone Agonists Have an Anti-apoptotic Effect on Cumulus Cells
P50
Q34662410-9223A1C6-A176-4E3C-AF1A-5C835399B2AAQ36409806-5CA17CC7-9B06-4220-8E6D-6135FADEC9E9Q36963384-A1AFC480-8129-453B-BA59-2EAAF0ACB1A8Q38296431-7D410FE7-65E0-4EC7-98F4-BB63910A7DC2Q40436062-71977311-693D-4ABD-922C-0917C64B7CE2Q40766038-D65B36D1-00C9-464E-B56B-FD99ADA50B6DQ43106184-995F6DA4-59DB-4BD5-BDF7-DB8C86F2F1D7Q43202772-4FC299A7-EBE3-41AB-97D9-967B1C8AE66EQ45105580-18992494-7D04-4EA0-8A02-56125C378254Q45174312-8BF447CE-0119-4603-820B-F1D29F43CCDFQ46319703-CF375F8E-82A1-4C02-BF9E-0F74B3EA6E0CQ46468031-90839F31-4004-4B89-BB6E-39FCF47A2581Q46937292-4BB352F6-C73F-4F91-8963-246F521C7CCAQ48618463-7BA85B6E-C453-4F74-BD96-95FF5DC052A0Q50633979-80E9851D-2D63-4073-A053-081BC8B8464BQ51153444-7CBFAC0B-3113-40CC-B1AA-159571541946Q53280953-23380D3D-F167-46ED-AD86-A3EEF8A63E6AQ58465926-67596941-170A-48A5-A67C-8BCBFD8594BCQ58736987-58AE5414-FD2A-4D64-9B5B-2161AEAAD5B7Q68423806-5DFAB6B1-4133-4393-A50E-7FB9DA877ECAQ69045190-00FFCA29-F92A-4362-BA4D-13D113491792Q69200529-32DBA8C6-EBDC-46E5-AC9B-3C194E8AB4FBQ69256619-A8DFB9E2-AF08-47EB-8A0B-AC35A82BCA7AQ75197210-5DD2A0CC-533B-4578-88F5-28BB91267115Q77535017-964F7F18-B6DC-4D34-8DE2-7B36398F77D9Q80739522-5E6FBAB6-6AA1-4319-BEB4-1CADE3BC829CQ80929795-405C959F-516F-49D9-A38F-13FD85C65D0AQ80961563-B96D61D9-37DC-488D-BB3A-1301004675E0Q81089099-6A612B4B-78F4-4C1E-BAE1-EAEE2D3D6DD1Q81481657-CA2B7977-1EE9-4331-A77B-88E7C5EB1A97Q81724124-D621C680-0E1D-4F09-ABC8-387790F6F5FCQ81750858-D81FBE38-8F41-493B-91C1-8A4268FD16D5Q81838452-683E3A59-86DD-4989-9D80-16FB96FCCADBQ82309143-2B54D64A-7EE0-4774-A3D6-C56E3005752BQ83180543-FC2F528E-89FD-4DA1-8D6D-85F568D34174Q83402462-C4898489-890C-488C-B0AE-D0D2D65768D2Q91692861-0D2C192A-5A15-4619-839C-01DDAE69A816
P50
description
researcher ORCID ID = 0000-0003-2546-2626
@en
wetenschapper
@nl
name
Paola Anserini
@ast
Paola Anserini
@en
Paola Anserini
@es
Paola Anserini
@nl
type
label
Paola Anserini
@ast
Paola Anserini
@en
Paola Anserini
@es
Paola Anserini
@nl
prefLabel
Paola Anserini
@ast
Paola Anserini
@en
Paola Anserini
@es
Paola Anserini
@nl
P106
P1153
6603931314
P21
P31
P496
0000-0003-2546-2626